L.I.A. Pure Capital reports ≤5% stake in Clearmind (CMND)
Rhea-AI Filing Summary
Clearmind Medicine Inc. amended a Schedule 13G/A reporting that L.I.A. Pure Capital Ltd. holds five percent or less of the company’s common shares as of 03/31/2026. The filing identifies the reporting person, its Israel address, and CUSIP 185053402.
Positive
- None.
Negative
- None.
Key Figures
Reporting date: 03/31/2026
Signature date: 05/15/2026
Ownership threshold: 5 percent or less
+1 more
4 metrics
Reporting date
03/31/2026
ownership as of reporting date
Signature date
05/15/2026
amendment signed by CEO Kfir Silberman
Ownership threshold
5 percent or less
declared ownership level in Schedule 13G/A
CUSIP
185053402
identifier for Clearmind common shares
Key Terms
Schedule 13G/A, Beneficially owned, CUSIP
3 terms
Schedule 13G/A regulatory
"Amendment No. 3 to a Schedule 13G/A reporting beneficial ownership"
A Schedule 13G/A is an amended public filing with the U.S. securities regulator that updates a previous Schedule 13G, disclosing when an individual or group holds a substantial (typically over 5%) stake in a company and is claiming a passive, non‑controlling intent. Investors monitor these updates because rising or falling holdings can signal changing confidence, potential future moves, or shifts in voting power — like watching a public ledger where large shareholders quietly adjust their positions.
Beneficially owned financial
"Amount beneficially owned: See items 5-11 of the cover pages hereto for beneficial ownership"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
CUSIP financial
"CUSIP No.: 185053402"
A CUSIP is a nine-character alphanumeric code that uniquely identifies a U.S. or Canadian financial security—such as a stock, bond, or fund share—like a Social Security number for an investment. It matters to investors because brokers, exchanges and record-keepers use the CUSIP to match trades, track ownership, settle transactions and pull accurate records, reducing errors and ensuring money and securities go to the right place.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
Does the Schedule 13G/A show L.I.A. Pure Capital owns more than 5% of CMND?
No. The filing states the reporting person holds 5 percent or less of the class. The Schedule 13G/A amendment lists L.I.A. Pure Capital Ltd. as the filer, references CUSIP 185053402, and records the reporting period 03/31/2026.
What entity filed the amendment to the Schedule 13G/A for CMND?
The filer is L.I.A. Pure Capital Ltd. The form gives the filer’s address at 20 Raoul Wallenberg Street, Tel Aviv, Israel and lists citizenship as Israel, signed by Kfir Silberman as CEO.
What date does the filing state for the reported ownership in CMND?
The ownership is reported as of 03/31/2026. The document is an Amendment No. 3 to a Schedule 13G/A and bears a signature date of 05/15/2026 from the filer’s CEO.
What class of securities is covered by this Schedule 13G/A amendment for CMND?
The filing covers Common Shares, no par value per share. The cover page lists the class title as Common Shares, no par value per share and includes the issuer address in Vancouver, British Columbia.
Who signed the Schedule 13G/A amendment for L.I.A. Pure Capital’s filing on CMND?
The filing is signed by Kfir Silberman, Chief Executive Officer. The signature block shows the name and title with a signature date of 05/15/2026 on the amendment document.